---
figid: PMC4343072__12964_2015_92_Fig6_HTML
figlink: /pmc/articles/PMC4343072/figure/Fig6/
number: F6
caption: 'Potential consequences of mutant BRAF V600E in LCH. In mutant monocytes
  or mutant LC precursors, the constitutively active BRAF V600E mutant protein is
  predicted to bypass the requirement for mitogen-induced activation of RAF by RAS.
  The identification of activating BRAF mutations supports the hypothesis that LCH
  is a neoplastic process (oncogenic potential). However, phosphorylated ERK is rapidly
  dephosphorylated by DUSP6, which is constitutively expressed in LCH cells (GSE16395).
  Other factors, such as accumulated gene mutations and an inflammatory trigger of
  the RAS/RAF/MEK/ERK signaling pathway, thus appear to be involved in LCH pathogenesis.
  DUSP6: dual specificity phosphatase 6.'
pmcid: PMC4343072
papertitle: Interleukin-1 loop model for pathogenesis of Langerhans cell histiocytosis.
reftext: Ichiro Murakami, et al. Cell Commun Signal. 2015;13:13.
pmc_ranked_result_index: '121146'
pathway_score: 0.9670548
filename: 12964_2015_92_Fig6_HTML.jpg
figtitle: Consequences of mutant BRAF V600E in LCH
year: '2015'
organisms: Homo sapiens
ndex: 402ef2b7-deca-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4343072__12964_2015_92_Fig6_HTML.html
  '@type': Dataset
  description: 'Potential consequences of mutant BRAF V600E in LCH. In mutant monocytes
    or mutant LC precursors, the constitutively active BRAF V600E mutant protein is
    predicted to bypass the requirement for mitogen-induced activation of RAF by RAS.
    The identification of activating BRAF mutations supports the hypothesis that LCH
    is a neoplastic process (oncogenic potential). However, phosphorylated ERK is
    rapidly dephosphorylated by DUSP6, which is constitutively expressed in LCH cells
    (GSE16395). Other factors, such as accumulated gene mutations and an inflammatory
    trigger of the RAS/RAF/MEK/ERK signaling pathway, thus appear to be involved in
    LCH pathogenesis. DUSP6: dual specificity phosphatase 6.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DUSP6
  - NRAS
  - MYD88
  - BRAF
  - MAP2K1
  - MAP2K2
  - ARAF
  - MAPK3
  - RAF1
  - TLR10
  - MAPK1
  - TLR1
  - RAPGEF5
  - IL1R1
  - TLR9
  - TLR3
  - TLR4
  - TLR5
  - KRAS
  - TLR6
  - TLR7
  - TLR8
  - HRAS
  - TLR2
  - EIF2AK3
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: DUSP6
  symbol: DUSP6
  source: hgnc_symbol
  hgnc_symbol: DUSP6
  entrez: '1848'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MYD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: (BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ARAF
  symbol: ARAF
  source: hgnc_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: CRAF
  symbol: c-Raf
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
- word: GFR
  symbol: GFR
  source: hgnc_alias_symbol
  hgnc_symbol: RAPGEF5
  entrez: '9771'
- word: IL-1R
  symbol: IL1R
  source: hgnc_prev_symbol
  hgnc_symbol: IL1R1
  entrez: '3554'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: PERK
  symbol: PERK
  source: hgnc_alias_symbol
  hgnc_symbol: EIF2AK3
  entrez: '9451'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC4343072__F6
redirect_from: /figures/PMC4343072__F6
figtype: Figure
---
